DR.CASH
Dr.Cash is a Brazilian fintech that enables healthcare clinics to offer patients installment payments (boleto parcelado) of up to 24x, with 48-hour settlement to clinics and full absorption of default risk. The São Paulo-based company serves SMB clinics across Brazil.
- Company typePrivate
- Founded2016
- HeadquartersSão Paulo, Brazil
- Headcount101–250
- GTM typeB2B
- OfferingServices
What DR.CASH does
DR.CASH is a Brazilian fintech company headquartered in São Paulo that provides receivables and payment infrastructure to healthcare clinics. Founded in 2016, the company enables clinics to offer patients installment payment plans of up to 24 installments via boleto parcelado, while guaranteeing clinics receipt of funds within 48 hours and absorbing all patient default risk. Its two core products are Boleto Parcelado para Clínicas, the installment payment engine, and Cadastro Expresso, a self-serve onboarding flow that credentials new clinics on the platform within minutes. Distribution is direct-to-clinic through the company's website (drcash.com.br) with dedicated portal access for registered clinics.
The underlying platform combines clinic onboarding (KYC/credentialing), patient installment plan origination, collections infrastructure, and receivables advance financing to clinics. By taking on default risk internally, Dr.Cash converts a structural barrier to installment selling for individual clinics into a serviceable product, with revenue generated via transaction fees on each installment payment processed. The company serves a fragmented SMB healthcare clinic base across Brazil, with no publicly disclosed pricing tiers or fee schedules — pricing appears to be quote-based per clinic arrangement. Headcount stands at 101-250 employees.
DR.CASH has raised approximately $10.74 million across two disclosed rounds: a 2021 seed led by Bossa Invest (with Incubate Fund participation) and a January 2023 Series A of roughly $10.45 million led by Banco Votorantim, a major Brazilian financial institution. The company is led by CEO Anastasia Perevoznikova. There is no disclosed information on M&A activity, patents, awards, strategic partnerships, or AI/ML capabilities, and the firm does not currently operate outside Brazil.
DR.CASH firmographics
Firmographics- Name
- DR.CASH
- Legal name
- Dr.Cash
- Website
- https://drcash.com.br
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Dr.Cash is a Brazilian fintech that enables healthcare clinics to offer patients installment payments (boleto parcelado) of up to 24x, with 48-hour settlement to clinics and full absorption of default risk. The São Paulo-based company serves SMB clinics across Brazil.
- Ownership category
- akta.pro rank
DR.CASH industry classification
Industry- Product category
- Healthcare Fintech / Patient Payment Solutions
- NAICS
- Financial Transactions Processing, Reserve, and Clearinghouse Activities (52232)
- SIC
- Hospital & Medical Service Plans (6324)
- akta.pro primary industry
- Consumer Electronics & Appliance Financing (FSAKAFAL)
- akta.pro secondary industry
- Patient Billing, Statements & Payment Processing (HLACACAG)
Keywords
Where DR.CASH is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Markets served
DR.CASH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Transaction-based installment payments: Dr.Cash generates revenue through transaction fees on installment payments processed for healthcare clinics. Clinics receive payment within 48 hours while patients pay in installments up to 24x.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
DR.CASH product offering
Product offeringCore offering
DR.CASH is a Brazilian fintech that provides healthcare clinics with an installment payment ticket (Boleto Parcelado) product, allowing patients to pay medical procedures in up to 24 installments while the clinic receives full payment within 48 hours and bears no default risk. Complementing this, the Cadastro Expresso service onboards new clinics onto the platform within minutes through an express registration flow. Together the two offerings form an integrated financial ecosystem tailored to the Brazilian healthcare sector.
Product overview
DR.CASH is a fintech platform offering financial solutions specifically designed for healthcare clinics. The product portfolio consists of two core offerings: Boleto Parcelado para Clínicas, which enables clinics to offer installment payment options (up to 24x) to patients with guaranteed 48-hour settlement and no default risk, and Cadastro Expresso, a rapid clinic onboarding service that credentials new clinics in minutes. These products work together as an integrated financial ecosystem for the healthcare sector.
Differentiator
Problem solved
Functional benefit
Products and services
- Boleto Parcelado para Clínicas A financial solution that enables healthcare clinics to offer patients installment payment plans of up to 24x via boleto (Brazilian payment ticket), with the clinic receiving full payment within 48 hours and zero default risk, since the platform absorbs patient credit risk and handles collections.
- Cadastro Expresso An express registration and credentialing service that onboards healthcare clinics onto the DR.CASH platform within minutes, enabling them to begin offering Boleto Parcelado installment plans to their patients almost immediately after signing up.
Companies that use DR.CASH
Customer profileSegments1 record
Ideal customer profiles1 record
DR.CASH technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
DR.CASH partnerships and signals
Strategic signalRecent moves4 records
Expansion highlights4 records
DR.CASH competitors and assessment
Company assessmentDirect peers
- Hiper: Brazilian fintech offering digital accounts, payment solutions, and credit/financing products tailored to small and mid-sized merchants, including healthcare-adjacent SMBs — directly comparable as a Brazil-focused fintech serving SMB merchants with embedded credit.
- Cobre Fácil: Brazilian fintech providing payment and working-capital solutions for SMBs and clinics; overlaps with Dr.Cash in serving Brazilian clinics with embedded financial products.
- Wellbe: Brazilian healthtech that builds financial and operational infrastructure for healthcare providers, directly comparable as a Brazil-based, healthcare-focused fintech serving clinics.
Emerging players
- Cora: Brazilian digital bank for SMBs offering accounts, payments, and credit products; overlaps with Dr.Cash's SMB-clinic target segment and embedded credit distribution model.
- Niwa: Brazilian fintech providing SMB working capital and credit; comparable as a transactional credit provider targeting underserved Brazilian SMBs, though broader than healthcare.
Others
- Banco Votorantim: Lead Series A investor in Dr.Cash and one of Brazil's largest private banks; a key strategic partner and potential distribution channel whose own merchant/healthcare credit products could overlap or accelerate Dr.Cash's reach.
Broad incumbents
- Mercado Pago: Payments and credit arm of MercadoLibre, offering installment plans and merchant credit across LatAm; broad incumbent whose merchant credit product competes with Dr.Cash's installment offering.
- PagBank / PagSeguro: Large Brazilian merchant acquirer and digital bank offering installment payment options to merchants; broad incumbent that competes in the same SMB merchant space, including healthcare.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
DR.CASH social profiles
Digital presenceDR.CASH financial estimates
Financial estimateRevenue estimate
Valuation estimate
DR.CASH leadership team
Management profileNumber of profiles
Profiles1 record
DR.CASH funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DR.CASH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DR.CASH
What does DR.CASH do?
DR.CASH is a Brazilian fintech that provides healthcare clinics with an installment payment ticket (Boleto Parcelado) product, allowing patients to pay medical procedures in up to 24 installments while the clinic receives full payment within 48 hours and bears no default risk. Complementing this, the Cadastro Expresso service onboards new clinics onto the platform within minutes through an express registration flow. Together the two offerings form an integrated financial ecosystem tailored to the Brazilian healthcare sector.
Is DR.CASH a public or private company?
DR.CASH is a private company. It is classified as venture growth investor backed and is currently operating.
When was DR.CASH founded?
DR.CASH was founded in 2016. It employs 101 to 250 people.
Where is DR.CASH based?
DR.CASH is headquartered in São Paulo, Brazil, in the Latin America region.
How does DR.CASH make money?
One revenue line is on record: transaction-based installment payments.
Who are DR.CASH's main competitors?
Direct peers on record are Hiper, Cobre Fácil and Wellbe. Emerging players are Cora and Niwa. Banco Votorantim is listed as an others. Broad incumbents are Mercado Pago and PagBank / PagSeguro.
Does DR.CASH have an API?
No public API is recorded for DR.CASH.
What industry is DR.CASH in?
DR.CASH's product category is Healthcare Fintech / Patient Payment Solutions. Its primary akta.pro industry code is FSAKAFAL, Consumer Electronics & Appliance Financing, with a secondary code of HLACACAG, Patient Billing, Statements & Payment Processing. Its NAICS code is 52232 and its SIC code is 6324.